基层口服降糖药物联合及起始胰岛素治疗2型糖尿病中国专家共识

2022-05-07 甘肃省人民医院内分泌代谢病诊疗中心 中国糖尿病杂志

广大基层医生面对如今诸多的降糖药物,常遇到如何开始糖尿病基础治疗、合理联合使用作用机制不同的口服降糖药(OAD)、OAD治疗血糖控制不达标如何起始不同类型胰岛素联合治疗、血糖达标后OAD联合胰岛素治疗

中文标题:

基层口服降糖药物联合及起始胰岛素治疗2型糖尿病中国专家共识

发布日期:

2022-05-07

简要介绍:

广大基层医生面对如今诸多的降糖药物,常遇到如何开始糖尿病基础治疗、合理联合使用作用机制不同的口服降糖药(OAD)、OAD治疗血糖控制不达标如何起始不同类型胰岛素联合治疗、血糖达标后OAD联合胰岛素治疗方案如何调整等问题,为此,中华医学会糖尿病学分会基层糖尿病防治学组专家以问答形式制订《基层口服降糖药物联合及起始胰岛素治疗2型糖尿病中国专家共识》(以下简称“共识”),旨在指导基层医生在T2DM治疗中,对饮食、运动和二甲双胍基础治疗血糖不达标的情况,根据患者血糖和HbA1c水平,合理进行OAD联合治疗及起始胰岛素治疗直至达标和达标后维持降糖治疗方案的优化。 

相关资料下载:
[AttachmentFileName(sort=1, fileName=基层口服降糖药物联合及起始胰岛素治疗2型糖尿病中国专家共识.pdf)] GetToolGuiderByIdResponse(projectId=1, id=abd3d1c002a3241f, title=基层口服降糖药物联合及起始胰岛素治疗2型糖尿病中国专家共识, enTitle=, guiderFrom=中国糖尿病杂志, authorId=0, author=, summary=广大基层医生面对如今诸多的降糖药物,常遇到如何开始糖尿病基础治疗、合理联合使用作用机制不同的口服降糖药(OAD)、OAD治疗血糖控制不达标如何起始不同类型胰岛素联合治疗、血糖达标后OAD联合胰岛素治疗, cover=https://img.medsci.cn/20220508/1652019943866_5579292.jpg, journalId=0, articlesId=null, associationId=2693, associationName=甘肃省人民医院内分泌代谢病诊疗中心, associationIntro=甘肃省人民医院内分泌代谢病诊疗中心, copyright=0, guiderPublishedTime=Sat May 07 00:00:00 CST 2022, originalUrl=, linkOutUrl=, content=<p><span style="color: #666666;">广大基层医生面对如今诸多的降糖药物,常遇到如何开始糖尿病基础治疗、合理联合使用作用机制不同的口服降糖药(OAD)、OAD治疗血糖控制不达标如何起始不同类型胰岛素联合治疗、血糖达标后OAD联合胰岛素治疗方案如何调整等问题,为此,中华医学会糖尿病学分会基层糖尿病防治学组专家以问答形式制订《基层口服降糖药物联合及起始胰岛素治疗2型糖尿病中国专家共识》(以下简称&ldquo;共识&rdquo;),旨在指导基层医生在T2DM治疗中,对饮食、运动和二甲双胍基础治疗血糖不达标的情况,根据患者血糖和HbA1c水平,合理进行OAD联合治疗及起始胰岛素治疗直至达标和达标后维持降糖治疗方案的优化。&nbsp;</span></p>, tagList=[TagDto(tagId=216, tagName=糖尿病), TagDto(tagId=2052, tagName=2型糖尿病), TagDto(tagId=31163, tagName=胰岛素治疗)], categoryList=[CategoryDto(categoryId=6, categoryName=内分泌, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=0, guiderKeyword=, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=4658, appHits=239, showAppHits=0, pcHits=346, showPcHits=4418, likes=1, shares=52, comments=2, approvalStatus=1, publishedTime=Mon May 09 15:22:00 CST 2022, publishedTimeString=2022-05-07, pcVisible=1, appVisible=1, editorId=0, editor=FUNNYMAN, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=3, createdBy=null, createdName=FUNNYMAN, createdTime=Sun May 08 22:27:17 CST 2022, updatedBy=5579292, updatedName=FUNNYMAN, updatedTime=Fri Jan 05 20:05:58 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=基层口服降糖药物联合及起始胰岛素治疗2型糖尿病中国专家共识.pdf)])
基层口服降糖药物联合及起始胰岛素治疗2型糖尿病中国专家共识.pdf
下载请点击:
评论区 (2)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1219034, encodeId=78a51219034c1, content=学习学习再学习!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c905475903, createdName=湘雅科教, createdTime=Thu May 12 12:37:43 CST 2022, time=2022-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218485, encodeId=78bd121848578, content=积分下载 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0efa5450543, createdName=呀撒西大魔王, createdTime=Tue May 10 16:24:47 CST 2022, time=2022-05-10, status=1, ipAttribution=)]
    2022-05-12 湘雅科教

    学习学习再学习!

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1219034, encodeId=78a51219034c1, content=学习学习再学习!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c905475903, createdName=湘雅科教, createdTime=Thu May 12 12:37:43 CST 2022, time=2022-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218485, encodeId=78bd121848578, content=积分下载 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0efa5450543, createdName=呀撒西大魔王, createdTime=Tue May 10 16:24:47 CST 2022, time=2022-05-10, status=1, ipAttribution=)]
    2022-05-10 呀撒西大魔王

    积分下载

    0